Aaron Cowen’s Moderna MRNA Stock Holding History

Aaron Cowen’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-205,593	Closed	-$6.06M	–	101
2025 Q4	$6.06M	Buy	+205,593	New	+$5.59M	0.12%	68
2025 Q3	–	Sell	-517,163	Closed	-$14.3M	–	102
2025 Q2	$14.3M	Hold	517,163	–	–	0.43%	52
2025 Q1	$14.7M	Buy	+517,163	New	+$18.4M	0.54%	48

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aaron Cowen's MRNA Position: Q1 2026 in Review

Aaron Cowen sold out of Moderna (MRNA) in Q1 2026, closing a stake of 205,593 shares — an estimated $6.06M sold.

Aaron Cowen first reported a position in MRNA in Q1 2025 and held it in 3 quarters. The position peaked at $14.7M in Q1 2025. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Aaron Cowen reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
Aaron Cowen sold 205,593 Moderna shares in Q1 2026, an estimated $6.06M.
Aaron Cowen first reported a position in Moderna in Q1 2025 and held it in 3 quarters.
Aaron Cowen's Moderna position peaked at $14.7M in Q1 2025.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.